152 related articles for article (PubMed ID: 32831648)
1. POLE2 knockdown reduce tumorigenesis in esophageal squamous cells.
Zhu Y; Chen G; Song Y; Chen Z; Chen X
Cancer Cell Int; 2020; 20():388. PubMed ID: 32831648
[TBL] [Abstract][Full Text] [Related]
2. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
3. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract][Full Text] [Related]
4. Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
Zhang C; Shen Y; Gao L; Wang X; Huang D; Xie X; Xu D; He H
Front Cell Dev Biol; 2021; 9():622344. PubMed ID: 33644060
[TBL] [Abstract][Full Text] [Related]
5. POLE2 knockdown suppresses lymphoma progression via downregulating Wnt/β-catenin signaling pathway.
Lv Z; Wu X; Lu P; Xu X; Wang J; Zhang C; Liu W; Gao Y; Lu C; Zhang Y; Kou H
Mol Cell Biochem; 2024 Mar; 479(3):487-497. PubMed ID: 37097331
[TBL] [Abstract][Full Text] [Related]
6. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
7. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
8. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma.
Zhao Z; Chu Y; Feng A; Zhang S; Wu H; Li Z; Sun M; Zhang L; Chen T; Xu M
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38436783
[TBL] [Abstract][Full Text] [Related]
9. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
10. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
12. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
13. ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.
Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y
Transl Cancer Res; 2020 May; 9(5):3282-3292. PubMed ID: 35117695
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
15. POLE2 promotes osteosarcoma progression by enhancing the stability of CD44.
Wang B; Hu H; Wang X; Shao Z; Shi D; Wu F; Liu J; Zhang Z; Li J; Xia Z; Liu W; Wu Q
Cell Death Discov; 2024 Apr; 10(1):177. PubMed ID: 38627379
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
17. PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways.
Zhao J; Jin G; Liu X; Wu K; Yang Y; He Z; Liu D; Zhang C; Zhu D; Jiao J; Li X; Zhao S
Cancer Cell Int; 2021 Nov; 21(1):637. PubMed ID: 34844621
[TBL] [Abstract][Full Text] [Related]
18. FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma
Zhou S; Zhang M; Zhou C; Meng Y; Yang H; Ye W
Front Oncol; 2021; 11():660955. PubMed ID: 33842377
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
20. circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.
Zhou S; Guo Z; Zhou C; Zhang Y; Wang S
Cancer Cell Int; 2021 May; 21(1):250. PubMed ID: 33957921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
